The enteroinsular axis in dipeptidyl peptidase IV-negative rats (Q28575083)

2

1 reference

31 January 2017

R. Pauly

3

1 reference

31 January 2017

H. Kofod

4

1 reference

31 January 2017

J. Kwong

5

1 reference

31 January 2017

C. H. McIntosh

Proline residues in the maturation and degradation of peptide hormones and neuropeptides

6

1 reference

31 January 2017

language of work or name

1 reference

1 November 1996

1 reference

31 January 2017

1 reference

31 January 2017

45

1 reference

31 January 2017

11

1 reference

31 January 2017

1335–1341

1 reference

31 January 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Deficiency of membrane-bound dipeptidyl aminopeptidase IV in a certain rat strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Effect of jejunoileal bypass in the rat on the enteroinsular axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Radioimmunoassay of gastric inhibitory polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Gastric Inhibitory Polypeptide (GIP) Stimulated by Fat Ingestion in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Stimulation of insulin secretion by gastric inhibitory polypeptide in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

The Insulinotropic Action of Gastric Inhibitory Polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Glucagon-like peptide-1 7-36: a physiological incretin in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Hyperglycaemia but not hyperinsulinaemia prevents the secretion of glucagon-like peptide-1 (7-36 amide) stimulated by fat ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Regulation of Intestinal Proglucagon- Derived Peptide Secretion by Intestinal Regulatory Peptides*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

The pharmacokinetics of porcine glucose-dependent insulinotropic polypeptide (GIP) in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2

Homologous Desensitization of the Insulinotropic Glucagon-Like Peptide-I(7–37) Receptor on Insulinoma (HIT-T15) Cells*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990112-2